Lowest Price Guaranteed
Pages
150
Last Updated
January 2026
View Count
15099
The global nutrigenomics market, valued at USD 0.92 billion in 2025, is projected to reach USD 1.04 billion in 2026 and USD 3.07 billion by 2035, with a 12.8% CAGR during the forecast period 2026 to 2035.
To learn more about this report, request a free sample copy
The new research study consists of industry trends, detailed market analysis, key market insights, market impact analysis, market forecast, and opportunity analysis. The growth in the opportunity for drug developers over the next decade is likely to be the result of the estimated increase in the demand for personalized therapeutics to treat patients.
Nutrigenomics typically refers to the study of the relationship between nutrition, human genomes, and health. The detailed analysis of the human genome and its interaction with nutrients helps researchers to develop tailor therapies for treating patients. Given the rising trend of personalized therapies for treating disease, there has been an increase in advanced next generation sequencing methods to analyze the human genome and its interaction with nutrients. It is estimated that there are around 20,000 genes present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. The advances in DNA sequencing technologies enable researchers to conduct in-depth genomic analysis at the molecular level for the development of precision medicines. Additionally, the successful outcomes of the human genome project that mapped the entire human DNA has also introduced the concept of nutritional genomics. It is worth highlighting here that extensive studies are currently being conducted to determine the role of nutrition and dietary regime over gene expression as well as human health. Though the nutritional genomics field is presently in a nascent stage, the increasing shift toward target-specific therapies has paved the path for personalized nutrition offerings.
 |
 |
 |
Driven by the rising awareness about food nutrition and its impact on human health, the nutrigenomics field is continually evolving to develop therapies that reduce the risk of numerous diet-associated diseases such as chronic respiratory diseases, cardiovascular diseases, diabetes, and oncological diseases. Presently, more than 100 companies are actively offering various types of nutrigenomics tests / services, including those emphasizing food intolerance / sensitivity, nutritional deficiency, nutrient metabolism, diet customization, disease risk assessment, and weight management globally. Notably, there are various companies engaged in this market to provide nutrigenomics test offerings to the customers, through online at home blood collection devices facilities and genetic test kits. It is worth noting here that more than 135 nutrigenetics-centric research articles have already been published, showcasing the initiatives of researchers to demonstrate the effects of nutrients in the regulation of genome expression. Despite increasing demand, the market witnesses several ethical and regulatory challenges and the risk of misusing personal data. As the researchers continue to focus on nutritional genomics to enhance therapeutic outcomes, the nutrigenomics market is anticipated to witness steady growth during the forecast period.
The market research report presents an in-depth analysis of various companies that are involved in the global nutrigenomics industry across different segments, as defined in the table below:
| Key Report Attribute | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Market Size in 2026 | USD 1.04 Billion | |
| Market Size in 2035 | USD 3.07 Billion | |
| Type of Sample |
|
|
| Type of Sample Collection Methods |
|
|
| Key Geographical Regions |
|
|
| Key Companies Nutrigenomics Market Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
|
|
The key objective of the market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics, and future opportunities for the nutrigenomics companies during the forecast period. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long-term for the forecast period till 2035. Our year-wise projections of the current and future opportunity within the market have further been segmented based on relevant parameters, such as [A] type of sample (saliva and other samples), [B] type of sample collection method (at-home sample collection and lab sample collection) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and Rest of the world). To account for future market uncertainties and add robustness to our model, we have provided three nutrigenomics market forecast scenarios, portraying the conservative, base, and optimistic tracks of the market's evolution.
The opinions and insights presented in the market report were also influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following individuals:
Further, all actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.
The global nutrigenomics industry is segmented into saliva and other samples based on the type of biological sample. According to our projection, saliva samples are poised to capture 75% of the overall revenue share by 2035. The saliva sample shows lucrative growth during the forecast period; this can be attributed to the ease of sample collection. Saliva sample segment is likely to grow at a CAGR of 14.5% by 2035.
The market is segmented based on the type of sample collection method into at-home sample collection and lab sample collection. According to our research, at-home sample collection is anticipated to capture 90% of the overall nutrigenomics market share by 2035. This can be attributed to the growing trends towards home healthcare, including diagnostic services which has improved to overall accessibility of diagnostic services. Further, at-home sample collection and lab sample collection are likely to grow at a compounded annual growth rate (CAGR) of 14.13% during the forecast period.
This segment highlights the distribution of the market across various geographical regions, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and the Rest of the World. According to our projection, North America will dominate the nutrigenomics industry and is anticipated to capture a share of 42% by 2035. Further, the nutrigenomics market in North America is expected to grow at a higher CAGR of 12.97% during the forecast period. Currently, several researchers across geographical regions have published literature reviews on nutrition and their impact on the human genome. Notably, 50% of the researchers who have published scientific literature on the effect of nutrition on the regulation of gene expression and its potential to cater to the requirement of personalized nutrition are established in Italy and the United States.
The ‘Nutrigenomics Market: Industry Trends and Global Forecasts, till 2035’ market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities for the nutrigenomics focused companies. The market research report features an in-depth analysis, highlighting the capabilities of nutrigenomics-focused companies.
Currently, the market landscape features over 100 players globally who claim to offer nutrigenomics tests / services on the basis of genetic assessment. It is interesting to note here that 80% of the firms engaged in the market operate via the business-to-customer (B2C) business model. Overall, the nutrigenomics industry seems well-fragmented, featuring small companies / start-ups established recently across different geographic regions. Additionally, more than 85% of the industrial players engaged in this market provide nutrigenomics tests to identify nutritional deficiencies, through at-home sample collection. Cardiovascular and metabolic disorders are considered to be widely targeted areas that have been evaluated under the nutrigenomics market. “Additionally, nutrigenomics helps in risk assessment of diet related disorders using the predictive power of single nucleotide polymorphism (SNP) genotyping.”
Several growth drivers propelled the nutrigenomics market during the forecast period. Some drivers include growing preferences for personalized therapies to treat chronic diseases and increasing awareness about the importance of a nutrient-rich diet in maintaining good health. Further, the growing risk of lifestyle-associated diseases such as cardiovascular disease, diabetes, and obesity has catered to the interest of key players in preventive healthcare strategies that require genomic analysis. In this context, nutrigenomics offers detailed information about human genomics and their interaction with nutritional elements. The information collected using nutrigenomics plays a pivotal role in developing personalized therapies.
It is interesting to note that several collaborations and partnerships have been inked between industrial leaders to consolidate their presence in the industry. The primary aim of alliances is to facilitate the development of innovative therapeutic solutions based on nutritional information combined with genetic insights. The strategic acquisitions aim to expedite personalized therapies based on nutrition information. In June 2023, SomaLogic entered into a partnership with Citogen with an aim to expand the authorized site program in Europe by utilizing SomaLogic’s 7,000-plex SomaScan® Platform for clinical research, population health studies and nutrigenomics.
Artificial intelligence has witnessed an upward trajectory in the pharmaceutical industry to facilitate drug discovery and development processes with real-time data analysis. The integration of nutrigenomics with artificial intelligence holds enormous opportunities to drive growth in this field. With the implication of artificial intelligence in nutrigenomics, researchers will be able to analyze large amounts of data and interpret research results in real-time. Moreover, the incorporation of machine learning algorithms enable researchers to process huge amounts of datasets with seamless accuracy, thereby improving precision of personalized nutrition recommendations and offer enormous opportunities to expand research on nutrigenomics. Furthermore, the implementation of data analytics software and technology facilitate the exploration of untapped demographics and tailoring nutrigenomics solutions to expand geographic reach.
The global nutrigenomics market is estimated to be worth USD 3.07 billion by 2035. Factors such as increasing demand for personalized therapies, focus on evaluating nutrition and their impact on human genomes is likely to drive the market during the forecast period. The market is anticipated to grow at a CAGR of 12.8% during the forecast period. In terms of targeted therapeutic areas, 49% of the market share is captured by cardiovascular disorders during the forecast period till 2035.
Examples of key nutrigenomics companies engaged in the market (which have also been profiled in this market report; the complete list of companies is available in the full report) include 3X4 Genetics, Advanced Nutrigenomics, DNAlysis Biotechnology, DNA Health and Wellness, Geno Palate, Mapymygenome, Nutrigenetics, Nutrigenomix, Vieroots, and Vitagenum. This market report includes an easily searchable excel database of all the companies working in the nutrigenomics industry, worldwide.
 |
 |
 |
The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing nutrigenomics services / tests.
Amongst other elements, the market report features:
 |
 |
Several recent developments have taken place in the field of the nutrigenomics. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall nutrigenomics market trends that have been outlined in our analysis.